NOW
ServiceNow, Inc.Close $103.30EOD onlyThis page reflects NOW options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
You are viewing an older report from March 31, 2026. A newer directional report is available for May 20, 2026.
View latest reportOutlook
Bearish with a strong gravitational pull toward $100-$102 support. Confidence: 6.5/10. The regime is defined by negative GEX (trending), bearish net premium flow, and spot trading below a declining max pain ladder. The primary conflict is the massive put OI floor at $85-$90, which may act as a magnet but also a potential buffer against a sharp collapse.
Conflicts: Massive DEX +25.4M shares suggests significant dealer long delta, which could slow a descent. Deep put OI at $85-$90 provides structural support.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-560K
DEX: +25.4M shares
Gamma flip: ~$90 (Approx — based on put OI concentration of 10,771)
NTM gamma: Gamma flip ~$90 is far below spot, confirming negative gamma regime. Dealer hedging will be reactive, not stabilizing — they buy on dips and sell on rallies, amplifying trends.
IV Analysis
IV vs VIX: IV 58.8% — Extremely high. Implies expensive options; selling premium has high nominal edge, but negative gamma increases risk of large moves.
Term structure: **Humped with a kink:** 4/24 expiry IV 63.6% > nearby (50.4%) and longer-dated (~55%). This kink likely prices the 4/22 earnings event. Steep drop after May.
Skew: **Earnings vol sale opportunity:** Sell 4/24 (63.6% IV) vs buy 5/01 (59.2% IV) or 6/18 (55.1% IV) for a calendar spread, betting on post-earnings vol crush.
Flow Analysis
Net premium: -$76.5M bearish; P/C Vol 1.46 (put dominance), P/C OI 0.88.
Directional prints: $100P 4/02 vol 152 vs OI 10,762 — likely opening of new downside protection or speculative puts. $105P vol 515 vs OI 8,610 — similar bearish activity near spot.
Unusual: $178P 6/18 vol 1,107 vs OI 190 at IV 100.1% — extreme vol purchase, likely a tail hedge or speculative downside bet.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Weak | N/A | Negative gamma and bearish flow oppose directional long bias. |
| Short Stock | Moderate-Strong | Entry near $105, stop above $108. | Dealer long delta (DEX +25.4M shares) could slow descent; put floor at $90. |
| Covered Call | Moderate | If long stock, sell $110C 4/17 (~45 DTE) for ~$2.00. | Stock decline outweighs premium; caps upside on any snap-back. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell $95/$90 put spread 4/17 (targeting put floor). | Break below $90 invalidates thesis; high IV provides good credit. |
| Long Calls | Weak | N/A — avoid buying calls against bearish flow and high IV. | IV crush and negative spot drift. |
| Long Puts / Bear Put Spread | Strong | Buy $102P / Sell $97P 4/10 (targeting $100-$102 zone). | High IV makes debit expensive; time decay. |
| Iron Condor | Moderate-Weak | $97/$92P x $112/$117C 4/17. (GEX negative & VIX contextually high). | Negative gamma increases chance of breaching a wing. |
| Calendar/Diagonal | Moderate-Strong | **Reverse Calendar (Bearish):** Sell $100P 4/24 (63.6% IV), Buy $100P 5/01 (59.2% IV). | Spot moves past short strike; earnings outcome. |
| PMCC / LEAPS Diagonal | Moderate-Weak | If executed, buy $90 LEAPS (1/15/27), sell 4/24 $115 calls against it. | Structural bearish bias makes LEAPS long delta risky. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.